News & Analysis on Clinical Trial Services & Contract Research And Development
Researchers in the UK have developed a tabletop DNA test laboratory that can cut the diagnosis of disease and infection from hours to 30 minutes. This new test laboratory will soon begin trials in UK hospitals.
OctoPlus, a drug delivery and development company, and InnoCore Technologies, a supplier of biodegradable polymeric drug delivery systems, announced a joint collaboration to develop and market a novel injectable drug delivery platform.
Israeli biotech firm Enzymotec has developed an enzyme technology that it claims will improve targeted delivery of nutrients in oils to human organs.
Swedish pump manufacturer Tapflo has launched a range of diaphragm pumps designed for environments in which there is a risk of explosion.
Cambrex has signed an exclusive license agreement that allows access to two novel, quantitative assay technologies for the detection of contaminants such as pathogens in drugs.
A pilot study organised by Accenture to explore the value of implementing radiofrequency identification (RFID) and electronic product code (EPC) technology in the pharmaceutical industry has concluded that there are numerous benefits.
In-Pharmatechnologist.com recently reported on the opening of a new biomanufacturing facility and laboratory by France's Lemnagene, a new company specialising in the production of recombinant proteins in duckweed. But why is duckweed such a promising...